Search results
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 6 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Kymera shares hold Buy rating on PoC data By Investing.com
Investing.com· 6 days agoWainwright maintained its Buy rating on Kymera Therapeutics (NASDAQ:KYMR) with a steady price target...
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 6 days agoBuilding on the data reported at the 2023 American Society of Hematology Annual Meeting...
New Standard of Care in High-Risk Acute Promyelocytic Leukemia?
MedPage Today· 7 days agoCombining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 6 days agoThe early results of the Phase II ELM-2 trial evaluating Regeneron’s Odronextamab as a new treatment...
Doing This One Thing on a Monthly Basis Could Help You Live 10 Years Longer, According to Research
Parade via Yahoo News· 1 day agoCertified Art Therapist with Four Diamonds at Penn State Health Children's Hospital has seen the...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 4 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
Roche shares hold as analyst backs Buy rating By Investing.com
Investing.com· 6 days agoThe endorsement follows Roche's presentation at the European Hematology Association (EHA) meeting...
Ultra-processed food, sedentary lifestyle fuelling cancers in Indians under 40: Doctors
Investing.com· 21 hours agoNew Delhi, June 23 (IANS) Poor lifestyle choices with regular consumption of ultra-processed foods,...
Glofitamab Regimen Improves Survival in DLBCL
MedPage Today· 4 days agoGranted accelerated approval last year, bispecific antibody passes its confirmatory test